Professor Yuan Guoyong, a professor of Hong Kong University, was hired by the Honorary

Yuan Guoyong, an expert in epidemiography in Hong Kong, was hired by the Honorary Dean of Shanghai Major Infectious Diseases and Biological Safety Research Institute.

According to the surging news report, at the 2023 Shanghai Infectious Disease Forum and 2023 Shanghai Medical Forum Parallel Forum on Tuesday (October 31), Yuan Guoyong, an academician of the Chinese Academy of Engineering and a professor at the University of Hong Kong Li Jiacheng Medical CollegeHonorary Dean of Shanghai Institute of Health Research.

Yuan Guoyong said at the forum that the forum witnessed the strategic start of the in -depth cooperation of Shanghai Institute of Pioneering and Research and the University of Hong Kong.He hopes that in the future, he will actively respond to global challenges brought by infectious diseases by studying cooperation, joint project application, and scholars' communication.

Public information shows that Yuan Guoyong, 67, was born in Hong Kong this year and was born in Guangzhou, Guangdong.He is a microbiologist, an infectious disease expert and a surgeon.Yuan Guoyong's research played a vital role in discovering the process of severe acute respiratory syndrome (SARS) coronary virus, which also made him pick the "Life Science Award" in the 2021 Future Science Award.

During the crown disease epidemic, Yuan Guoyong and others published a paper on the "New Crown Virus" in The Lancet in January 2020.In August 2020, Yuan Guoyong and Professor Huang Jiandong of the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences jointly published a paper, which confirmed for the first time that coronary virus can infect human neural ancestral cells and brain organs that can be trained in vitro.

According to the official website, the Shanghai Major Infectious Diseases and Biological Safety Research Institute was established in November 2020 at Fudan University.mechanism.The research direction of the institute includes major infectious disease pathogens and biological safety research and technical transformation, and major infectious diseases and biological safety prevention and control strategies and policy research.